AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 48 filers reported holding AGILE THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $1,886,000 | -65.4% | 1,591,652 | +30.3% | 0.08% | -68.6% |
Q3 2017 | $5,449,000 | +52.1% | 1,221,775 | +27.9% | 0.24% | +28.3% |
Q2 2017 | $3,582,000 | +15.0% | 955,109 | -1.7% | 0.19% | +59.2% |
Q1 2017 | $3,114,000 | +37.2% | 971,739 | +144.2% | 0.12% | +29.0% |
Q4 2016 | $2,269,000 | +30.0% | 398,000 | +59.2% | 0.09% | +14.8% |
Q3 2016 | $1,745,000 | -8.3% | 250,000 | 0.0% | 0.08% | +8.0% |
Q2 2016 | $1,903,000 | +22.5% | 250,000 | 0.0% | 0.08% | +13.6% |
Q1 2016 | $1,553,000 | +59.6% | 250,000 | +138.1% | 0.07% | +106.2% |
Q1 2015 | $973,000 | +50.9% | 105,000 | 0.0% | 0.03% | +39.1% |
Q4 2014 | $645,000 | -15.9% | 105,000 | 0.0% | 0.02% | -17.9% |
Q3 2014 | $767,000 | -15.2% | 105,000 | +1.3% | 0.03% | -22.2% |
Q2 2014 | $904,000 | – | 103,613 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ProQuest Associates IV LLC | 5,062,363 | $18,984,000 | 24.27% |
CAXTON CORP | 1,623,567 | $6,088,000 | 9.50% |
Vivo Capital, LLC | 1,513,975 | $5,677,000 | 1.43% |
Aisling Capital LLC | 1,804,933 | $6,768,000 | 1.16% |
INVESTOR AB | 3,510,189 | $13,163,000 | 0.92% |
Cormorant Asset Management, LP | 1,250,000 | $4,688,000 | 0.78% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 430,000 | $1,613,000 | 0.43% |
PURA VIDA INVESTMENTS, LLC | 174,501 | $654,000 | 0.26% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 955,109 | $3,582,000 | 0.19% |
ELEMENT CAPITAL MANAGEMENT LLC | 61,052 | $229,000 | 0.05% |